< Terug naar vorige pagina

Octrooi

Means and methods for anti-vegf therapy

The present application relates to the field of cancer, particularly to colorectal cancer (CRC). A panel of biomarkers is presented hereinthat can be used to cluster CRC samples into distinct genetic subtypes. It further relates to the use of the clustering method on patients treated with an anti-VEGF therapy and the identification of anti-VEGF responsive genetic subtypes.
Octrooi-publicatienummer: WO2017182656
Bron: WIPO
Jaar aanvraag: 2017
Jaar aanvraag: 2018
Jaar van publicatie: 2017
Status: Requested
Technologiedomeinen: Biotechnology
Gevalideerd voor IOF-sleutel: Ja
Toegewezen aan: Associatie KULeuven